Research Paper Volume 15, Issue 11 pp 4757—4773

Knocking down NSUN5 inhibits the development of clear cell renal cell carcinoma by inhibiting the p53 pathway


Figure 9. Verify the tumorigenic effect of NSUN5 in vivo. (A) The image of subcutaneous xenograft tumors of 786-O cells transfected with sh-NC and sh-NSUN5. (B) The curve of xenograft volume over time. (C) The comparison of tumor weight between the two groups. (D) Detection of NSUN5 expression in two groups of tumors. The data are shown as mean ± SD (*P < 0.05, ****P < 0.0001).